Skip to Content
Return to Navigation

Sinovac Says Early Data Show its Covid-19 Vaccine Generated Immune Responses-STAT, 6/14

Sinovac Biotech announced preliminary study results on Saturday showing its experimental Covid-19 vaccine generated immune responses in patients and was safe — early data that suggest it might protect people against infections with the novel coronavirus. STAT, 06/14/2020

Share this article: